News & Updates
Filter by Specialty:
Show Multimedia Only

Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
08 Aug 2024
byStephen Padilla
In patients with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy (LOT), treatment with belantamab mafodotin (belamaf) plus pomalidomide and dexamethasone (BPD) results in statistically significant and clinically meaningful progressive-free survival (PFS) compared with pomalidomide plus bortezomib and dexamethasone (PVD), as shown in the DREAMM-8 study.
Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma
08 Aug 2024
New risk factor identified for sudden infant death: Maternal obesity
08 Aug 2024
byJairia Dela Cruz
Infants born to mothers with prepregnancy obesity are at risk of sudden unexpected infant death (SUID), with the risk increase commensurate with maternal BMI, according to a large US nationwide cohort study.